Suggested Topics within your search.
Suggested Topics within your search.
-
2701
-
2702
-
2703
-
2704
-
2705
-
2706
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
Published 2025-03-01“…Methods: This multicenter, open-label, phase 2 trial involved 42 institutions across Japan. Eligible participants had metastatic or recurrent nonsquamous NSCLC without sensitizing EGFR or ALK alterations, were aged 75 years or above, had a programmed cell death-ligand 1 tumor proportion score of less than 50%, had not undergone systemic chemotherapy, and had an Eastern Cooperative Oncology Group performance status of 0 or 1. …”
Get full text
Article -
2707
A cross-sectional study on achievement of performances of Kayakalp program parameters between a Medical College and District Hospital of West Bengal
Published 2024-10-01“…Conclusion All health institutions should be under the Kayakalp program for improvement in the quality of patient care-related services.…”
Get full text
Article -
2708
-
2709
-
2710
-
2711
Weight Loss and Engagement in a Tirzepatide-Supported Digital Obesity Program: A Four-Arm Patient-Blinded Retrospective Cohort Study
Published 2024-04-01“…However, the world’s major health institutions emphasize that pharmacotherapy should only ever be used as an adjunct to lifestyle coaching. …”
Get full text
Article -
2712
-
2713
-
2714
-
2715
-
2716
-
2717
-
2718
-
2719
-
2720